几乎没有,但存在:血管素转化酶抑制剂诱导的血管
Muhammad Asad Butt1, Santosh Kumar2, Syed Muaaz Sarwer1
1Anaesthesiology, Tipperary University Hospital, Clonmel, IRL.
Cureus
|November 10, 2025
概括
ангиотензин转化酶抑制剂 (ACEI) 诱导的血管引起了严重的上呼吸道胀,需要内内输管. 及时识别药物历史对于管理这种罕见的,危及生命的疾病至关重要.
科学领域:
- 内部医学 内部医学
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
背景情况:
- ангиотензин转化酶抑制剂 (ACEI) 广泛用于高血压,心力衰竭和慢性病.
- 由ACEI诱导的血管瘤是一种罕见但可能危及生命的不良反应.
- 上呼吸道可以呈现为紧急情况,模仿其他疾病,如过敏反应或路德维希心痛.
研究的目的:
- 报告一个严重的上呼吸道的情况,这是ACEI诱导的血管的次要原因.
- 为了强调在诊断和管理这种疾病时,彻底服用药物的历史的重要性.
- 讨论需要呼吸道干预的ACEI诱导的血管的管理.
主要方法:
- 一个62岁的女性患者的病例报告显示上呼吸道胀.
- 事故和紧急情况 (A&E) 部门的初始管理包括氧气,上腺素,甲,雾化和抗生素.
- 气道管理涉及由于渐进的而导致的内管内输入,随后是保守的管理和通风.
主要成果:
- 患者的上呼吸道胀被诊断为ACEI诱导的血管.
- 尽管进行了初步的医疗干预,但仍需要进行内管道输入,以确保气道的安全.
- 保守的管理与通风导致胀的解决,手术干预不需要.
结论:
- 由ACEI诱导的血管瘤是一个关键的诊断,需要迅速识别,通常是由详细的药物历史引起的.
- 气道损伤是一个很大的风险,需要密切监测和潜在的输管.
- 保守的管理和机械通风可以有效地解决严重的ACEI诱导的血管.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
902
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
902
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
428
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
428
01:28Cardiac Catheterization I: Pre-Procedure Overview
1.0K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.0K